{"id":18477,"date":"2017-12-04T10:55:02","date_gmt":"2017-12-04T18:55:02","guid":{"rendered":"https:\/\/sop.washington.edu\/?page_id=18477"},"modified":"2026-05-04T16:01:54","modified_gmt":"2026-05-04T23:01:54","slug":"phenom","status":"publish","type":"page","link":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/","title":{"rendered":"Program in Health Economics and Outcomes Research Methodology (PHEnOM)"},"content":{"rendered":"

The Program in Health Economics and Outcomes Research Methodology (PHEnOM)<\/strong> at The CHOICE Institute is a joint program with the Department of Health Systems & Population Health in the School of Public Health at the University of Washington, Seattle. The program aims to facilitate intellectual activities within the departments in the fields of health economics, econometrics and methodology development in outcomes research and to engage researchers in allied fields. Key competencies of PHEnOM affiliates include health econometrics, health policy evaluation, applications in health capital, aging and disability, organization of health care, simulations methods, and comparative and cost-effectiveness analysis.<\/p>\n

The PHEnOM Seminar is also offered as a 1 credit course to interested students. The course, HEOR 598, is a great opportunity for students to receive credit for attending and participating in our weekly research seminars. Please contact us if you have any questions on the details of the course.<\/p>\n

Subscribe<\/a> to the phenom-info email list.<\/p>\n

PHEnOM Co-Directors<\/h3>\n

\"\"Douglas Barthold, PhD<\/strong><\/h4>\n

Dr. Douglas Barthold joined the Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute faculty in 2018, after completing a postdoctoral fellowship at the Schaeffer Center for Health Policy and Economics at the University of Southern California. He received his Ph.D. in Economics from McGill University in 2015, with a specialization in empirical health economics. Dr. Barthold is broadly interested in the relationships between health policies, healthcare utilization, and health outcomes and inequalities. His current research examines the intersection between health policies, chronic disease management, and cognition, from mid-life to end-of-life. This includes the role of health policies in the management of mid-life risk factors for Alzheimer\u2019s disease and related dementias (ADRD), as well as the value of care for conditions that influence healthy aging. Read more: https:\/\/sop.washington.edu\/people\/douglas-barthold<\/a><\/p>\n

\"\"<\/p>\n

Jing Li, PhD<\/strong><\/h4>\n

Dr. Jing Li is an Associate Professor of Health Economics at the CHOICE Institute with research interests in the economic, social and behavioral factors affecting individual decision-making in health and healthcare, for both providers and patients (especially older adults with cognitive impairment), and the impact of policies that leverage these factors to improve patient outcomes and healthcare market efficiency. Methodologically, she is interested in innovatively applying advanced experimental and econometric methods to addressing understudied questions in health economics and policy. Dr. Li was a faculty at Cornell University prior to joining UW. She received a PhD in Health Economics and MA in Economics from University of California, Berkeley, and an MA in International Comparative Education from Stanford University. Read more: https:\/\/sop.washington.edu\/people\/jing-li\/<\/a><\/p>\n

Past Co-Directors: Jerome Dugan, PhD, Norma Coe, PhD<\/a>, Anirban Basu, PhD<\/a><\/strong><\/p>\n

PHEnOM Seminar Series<\/h2>\n

PHEnOM hosts a weekly seminar series during the academic year. All students, faculty and other researchers interested in this area are welcome to attend the seminar series.\u00a0 The seminar is offered in-person and by Zoom on Wednesday 3 – 4:30pm. In-Person Location: Department of Pharmacy Conference Room, H-371. For the Zoom link,<\/strong> please contact the seminar organizers or subscribe to our list-serv<\/a>. To present or attend the PHEnOM seminar series, contact Douglas Barthold at barthold@uw.edu<\/a> or Jing Li at jli0321@uw.edu<\/a>.<\/em><\/p>\n

2026 Spring Quarter Seminar Schedule<\/h3>\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Dates<\/strong><\/th>\nSpeaker<\/strong><\/th>\nTitle<\/strong><\/th>\n<\/tr>\n
Apr 1<\/strong><\/td>\nAlexandr Kostyuk<\/strong><\/p>\n

Fulbright Visiting Scholar
\nUniversity of California, Davis<\/em><\/td>\n

Health Coverage Decision Making in Kazakhstan: The Role of Health Technology Assessment, Policy Challenges, and Emerging Solutions<\/td>\n<\/tr>\n
Apr 8<\/strong><\/td>\nDrishti Baid<\/strong><\/p>\n

PhD Candidate
\nUniversity of Southern California<\/em><\/td>\n

Does Brand-to-Brand Competition Reduce Prices of Prescription Drugs?<\/td>\n<\/tr>\n
Apr 15<\/strong><\/td>\nNo seminar<\/td>\n<\/td>\n<\/tr>\n
Apr 22<\/strong><\/td>\nKara Rudolph<\/strong><\/p>\n

Associate Professor of Epidemiology
\nColumbia University<\/em><\/td>\n

 Improving Efficiency in Estimating Transported Average Treatment Effects<\/span><\/td>\n<\/tr>\n
Apr 29<\/strong><\/td>\nSumedha Gupta<\/strong><\/p>\n

Associate Professor of Economics
\nIndiana University Indianapolis<\/em><\/td>\n

Regulatory Frictions, Prescribing Behavior, and Unintended Consequences: Evidence from Gabapentin Policies<\/span><\/td>\n<\/tr>\n
May 6<\/strong><\/td>\nMichael M\u00f6ller<\/strong><\/p>\n

PhD Candidate<\/p>\n

Hamburg Center for Health Economics, University of Hamburg<\/em><\/td>\n

Estimating Heterogeneous Treatment Effects of Integrated Community Healthcare Using Machine Learning<\/td>\n<\/tr>\n
May 13<\/strong><\/td>\nGenevieve Kanter<\/strong><\/p>\n

Associate Professor of Public Policy
\nUniversity of Southern California<\/em><\/td>\n

Managing Conflicts of Interest and Industry Influence in FDA Advisory Committees<\/span><\/td>\n<\/tr>\n
May 20<\/strong><\/td>\nNo seminar (ISPOR)<\/em><\/td>\n<\/td>\n<\/tr>\n
May 27<\/strong><\/td>\nEthan Ashby<\/strong><\/p>\n

PhD Candidate in Biostatistics
\nUniversity of Washington<\/em><\/td>\n

Methodological Advances in Using Negative Control Endpoints to Improve Vaccine Effectiveness Estimation<\/td>\n<\/tr>\n
Jun 3<\/strong><\/td>\nLast Wednesday – no seminar<\/em><\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

Seminar Archives<\/h3>\n
\n
2026<\/span>2025<\/span>2024<\/span>2023<\/span>2022<\/span>2021<\/span>2020<\/span>2019<\/span>2018<\/span>2017<\/span>2016<\/span>2015<\/span>2014<\/span>2013<\/span>2012<\/span><\/div>\n
\n
\n

Jan 14
\nCatherine Ishitani
\nIn Defense of the Middleman: Quality Failures in the Generic Pharmaceutical Market<\/p>\n

Jan 21
\nSerena Guo
\nReal World Evidence on GLP-1 Receptor Agonists: Insights into Alzheimer\u2019s Disease and Related Dementias (ADRD) and beyond<\/p>\n

Jan 28
\nKate Johnson
\nThe Value of Air Cleaners for Reducing the Health Impacts of Climate Change in British Columbia<\/p>\n

Feb 4
\nSheena Sullivan
\nPitfalls of using electronic health records for estimating vaccine effectiveness<\/p>\n

Feb 11
\nJack Chapel
\nThe value of timely initiation of anti-amyloid therapy for Alzheimer\u2019s disease<\/p>\n

Mar 4
\nHuiwen Xu
\nVisitation restrictions and COVID-19 infections in nursing homes<\/p>\n<\/div>\n

\n

Jan 15
\nDonghoon Lee
\nAdvancing Mental Health Care for Older Adults: Evidence from Medicare<\/p>\n

Jan 22
\nVirat Agrawal
\nUnderstanding the effects of Housing Inflation on Household Alcohol and Tobacco Purchases using a DDD approach<\/p>\n

Jan 29
\nDavid Kim
\nSimulation Modeling to Inform Health Policy Decisions: Development, Validation, and Application of the Diabetes, Obesity, Cardiovascular Disease Microsimulation (DOC-M) Model<\/p>\n

Feb 5
\nLanting Yang
\nReal-World Insights into Clinical and Pharmaceutical Outcomes of Sodium Glucose Cotransporter 2 Inhibitors<\/p>\n

Feb 12
\nJohn Giardina
\nAccurate evaluation of primary prevention policies using joint longitudinal and time-to-event models<\/p>\n

Feb 19
\nChristopher Whaley
\nCorporate Practice of Medicine: Vertical Alignment and Medicare Advantage Risk Coding<\/p>\n

Feb 26
\nKyla Woodward
\nUsing US labor data to understand health workforce trends<\/p>\n

Mar 5
\nYanfang Su
\nImpact of China\u2019s \u2018Zero-markup Policy for Essential Drugs\u2019 on patients, county hospital revenue, and government subsidy levels<\/p>\n

Apr 2
\nFirst Wednesday – no seminar<\/p>\n

Apr 9
\nDavene Wright
\nThe GLP-1 Hunger Games: Developing Innovative Ideas That Will Catch Fire<\/p>\n

Apr 16
\nKevin Duan
\nThe Impact of the Medicare Competitive Bidding Program on Supplemental Oxygen in COPD<\/p>\n

Apr 23
\nMinttu Ronn
\nRacial and ethnic disparities in congenital syphilis: analyzing the role of inequalities in prenatal care<\/p>\n

Apr 30
\nTess Ryckman
\nModelling the health &amp; cost benefits of improved regimens to treat TB: which regimen characteristics matter the most?<\/p>\n

May 7
\nCarolyn Rutter
\nWhat I think about when I think about calibrating<\/p>\n

May 14
\nISPOR – no seminar<\/p>\n

May 21
\nRescheduled to Jun 4<\/p>\n

May 28
\nHawre Jalal
\nUnderstanding the Exponential Growth of Opioid Overdose Deaths: Patterns, Drivers, and Lessons from the COVID-19 Era<\/p>\n

Jun 4
\nSteven Shechter
\nOptimal matching problems in health care<\/p>\n

24-Sep
\nFirst Wednesday – no seminar<\/p>\n

1-Oct
\nP\u00e9ter Hudomiet
\nPopulation trends and disparities in dementia prevalence in the U.S. and in the accuracy of claims-based dementia classifications in Medicare data<\/p>\n

8-Oct
\nNo seminar<\/p>\n

15-Oct
\nJong Min Jung
\nGet Fit with MA? Estimating the impact of Medicare Advantage on Physical Activity<\/p>\n

22-Oct
\nPatrick Carlin
\nInstitutional Trust and Preventative Health Behaviors<\/p>\n

29-Oct
\nBulat Idrisov
\nHIV and Substance Use Disorders in U.S. Healthcare Spending, 2010\u20132019: Individual Costs, County Trends, and State-Level Efficiency<\/p>\n

5-Nov
\nJianan Yang
\nDrug Procurement, Affordability, and Patient Welfare: Evidence from Centralized Price Negotiation in China<\/p>\n

12-Nov
\nKatherine Wen
\nThe Health and Employment Effects of Employer Vaccination Mandates<\/p>\n

19-Nov
\nNick Bansback
\nImproving Enrollment in Clinical Trials using Economic Methods: Development of the I-PARTICIPATE approach<\/p>\n

26-Nov
\nThanksgiving – no seminar<\/p>\n

3-Dec
\nLast Wednesday – no seminar<\/p>\n<\/div>\n

\n

Jan 10
\nLogan Trenaman
\nOrdering choice sets by complexity in a discrete choice experiment can reduce self-reported attribute non-attendance<\/p>\n

Jan 17
\nShiven Bhardwaj and Jennifer Bacci
\nExploring Association Between Receipt of Pediatric Vaccine at Pharmacy and Timeliness of Well-Child Visits<\/p>\n

Jan 24
\nLucy Hong and Cheng Chen
\nEvaluating E-Cigarette Sales Restrictions: Insights into Consumption and Substitution Behavior.<\/p>\n

Jan 31
\nGraeme Peterson
\nThe Geography of Health Disparities<\/p>\n

Feb 14
\nZiyue Xu
\nFracking Boom and Respiratory Health: Evidence from Texas<\/p>\n

Feb 21
\nMaitreyi Sahu
\nLinking drugs to diagnoses: generating a probabilistic map using Market Scan claims data<\/p>\n

Feb 28
\nZhang Zhang
\nThe Evaluation of Telehealth Provider Payment Parity on Health Service Utilization among Working-age Population with Chronic Conditions in the US<\/p>\n

Apr 3
\nJorge Rivero
\nType fixed effects and rational addiction:\u00a0A GMM framework for latent type heterogeneity<\/p>\n

Apr 10
\nErfan Loghmani
\nInvestigating the Impact of Advertising on Smoking Cessation: The Important Role of DTC Prescription Drug Advertising<\/p>\n

Apr 17
\nFelipe Montano-Campos
\nBridging Data Gaps and Predicting Future Trends: A Local Imputation and Prediction Algorithm for Continuous Biomarker Monitoring in Chronic Myeloid Leukemia<\/p>\n

Apr 24
\nAnirban Basu
\nDynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies<\/p>\n

May 1
\nLauren Nicholas
\nHow Do Surrogates Make Treatment Decisions for Patients with Dementia?\u00a0 An Experimental Survey Study<\/p>\n

May 15
\nEsha Dwibedi
\nChanges in lifetime spending and health-adjusted life-expectancy in the United States, 1996 to 2016<\/p>\n

May 22
\nRiley League
\nAdministrative Burden and Consolidation in Health Care: Evidence from Medicare Contractor Transitions<\/p>\n

Oct 2
\nPinka Chatterji (presenting author), Chun-Yu Ho, Wenqing Li
\nQuality effects of nursing home mergers<\/p>\n

Oct 9
\nHarsha Amaravadi
\nToo Sick to Be True? Evaluating Problematic Coding Practices in Medicare’s Patient Driven Payment Model<\/p>\n

Oct 16
\nKelly Anderson
\nMeasuring the Effects of Pharmacy Closures<\/p>\n

Oct 23
\nYongkang Zhang
\nWhat Do We Know About Long COVID? Evidence from NIH RECOVER Initiative<\/p>\n

Nov 6
\nDiane Cook
\nData Mining a Digital Twin for Cognitive Health Assessment and Intervention<\/p>\n

Nov 13
\nSijiu Wang
\nPredictors of Medicaid Enrollment Among Older Adults with Dementia<\/p>\n

Nov 20
\nOmar Galarraga
\nEvaluating Policies Implemented at the National Level: Double and Triple Difference Applications in Ecuador<\/p>\n<\/div>\n

\n

Jan 18
\nMark Meiselbach
\nMinimum Wage Laws and the Design and Provision of Employer-Sponsored Health Insurance<\/p>\n

Jan 25
\nHoa Vu
\nThe Effects of Residential Segregation on Infant Health<\/p>\n

Feb 1
\nValentyn Litvin
\nTried and True or New and Improved? Using Clinical Guidelines to Balance Innovation and Expertise<\/p>\n

Feb 8
\nVikesh Amin
\nDoes Schooling Improve Cognitive Abilities at Older Ages: Causal Evidence from Nonparametric Bounds<\/p>\n

Feb 15
\nJens Grueger
\nMarket Access and Implications of IRA beyond the U.S.<\/p>\n

Feb 22
\nHawre Jalal
\nDynamics of Opioid and Drug Overdoses in the United States and Opportunities for Interventions<\/p>\n

Mar 29
\nYunfei Li
\nAdvancing infectious disease modeling for public health decision-making<\/p>\n

Apr 5
\nMelissa Mugambi
\nDeveloping attributes and levels for a discrete choice experiment to design pharmacy-based HIV prevention services for pregnant women in Western Kenya<\/p>\n

Apr 12
\nAlton Russell
\nInforming targeted public health measures with data-driven decision modeling<\/p>\n

Apr 19
\nDan Zeltzer
\nThe Impact of Increased Access to Telemedicine<\/p>\n

Apr 26
\nJakub Hlavka
\nThe Economics of Disease-Modifying Therapies in Alzheimer\u2019s Disease<\/p>\n

May 17
\nMelissa Knox
\nUsing Electronic Health Records for Policy Evaluation: The Case of Seattle\u2019s Sweetened Beverage Tax<\/p>\n

May 24
\nRamanan Laxminarayan (hosted by the Economics Department \u2013 Savery Hall 130)
\nOn the Value of Disease Surveillance<\/p>\n

Oct 4
\nXiaoxue Li
\nThe Effect of State EITC Expansions on Alcohol Purchase: Evidence from Nielsen Consumer Panel Data<\/p>\n

Oct 11
\nParker Rogers
\nRegulating the Innovators: Approval Costs and Innovation in Medical Technologies<\/p>\n

Oct 18
\nKandice Kapinos
\nLong-Acting Reversible Contraceptives and Adolescent Childbearing: Changes in Clinical Guidelines for Intrauterine Devices<\/p>\n

Nov 1
\nMonisha Sharma
\nMaximum price threshold for long-acting PrEP in sub-Saharan Africa: a modeling analysis<\/p>\n

Nov 8
\nAntonio Moreno Llamas
\nDifferences in self-rated health status, mental health symptoms, and physical functioning comparing Spanish and US health surveys in individuals with chronic diseases<\/p>\n

Nov 15
\nHyunju Kim
\nBiomarkers of Dietary Approaches to Stop Hypertension (DASH) diet and blood pressure reduction<\/p>\n

Nov 29
\nStipica Mudrazija
\nCurrent and Future Costs of Caregiving for Older Adults with Alzheimer’s Disease and Related Dementias<\/p>\n<\/div>\n

\n

Jan 5
\nBrandyn Churchill
\nAdult Vaccine Recommendations: Morbidity and Firm Response<\/p>\n

Jan 12
\nKyu Eun Lee
\nForecasting the Burden of Disease Using Simulation Models<\/p>\n

Jan 19
\nFerdous Sardar
\nAdoption and Impact of Mobile Health Services: Experimental Evidence from Bangladesh<\/p>\n

Jan 26
\nNoah Hammarlund
\nIsolating the Drivers of Racial Disparities in Emergency Cardiac Surgery<\/p>\n

Feb 2
\nChuck Phelps
\nAdvances in GRACE methodology<\/p>\n

Feb 9
\nCarol Levin
\nEconomic evaluation of complex interventions.\u00a0 Overview, Application and Results from the Strengthening Economic Evaluation of Multisectoral Strategies for Nutrition (SEEMS-Nutrition)<\/p>\n

Feb 16
\nKaren Smith
\nQuasi-experimental versus observational methods for modeling the outcomes of blood pressure changes<\/p>\n

Feb 23
\nSherri Rose
\nFairness and Generalizing to Target Populations<\/p>\n

Mar 9
\nEnrique Saldarriaga
\nUsing sociodemographic and political data to identify COVID-19 vaccine hesitancy predictors<\/p>\n

Apr 6
\nKevin Lu
\nTrends and effects of health insurance plans with chronic conditions<\/p>\n

Apr 13
\nVilsa Curto
\nPrice, Steering, and Utilization Effects of Vertical Integration between Physicians and Hospitals<\/p>\n

Apr 20
\nEmily Ann Cuddy
\nRules vs. Discretion: Treatment of Mental Illness in US Adolescents<\/p>\n

Apr 27
\nAnirban Basu
\nRace in Algorithms<\/p>\n

May 11
\nBoshen Jiao
\nEconomic Value of Expanding First-Line Treatment Choices<\/p>\n

Jun 1
\nSusan E. Bronskill
\nHealth system use and outcomes in persons living with dementia: what can we learn from population-based data?<\/p>\n

Sep 28
\nKayleigh Barnes
\nThe Pink Tax: Gender Differences in Consumption Spending<\/p>\n

Oct 5
\nMin Hee Kim
\nMechanistic pathways linking neighborhood disadvantage with cardiovascular risk factors: Quasi-experimental evidence from a refugee dispersal policy in Denmark<\/p>\n

Oct 12
\nJing Li
\nDementia and Long-run Trajectories\u00a0in Household Finances<\/p>\n

Oct 19
\nJiani Yu
\nPhysician Management Companies and Prices, Utilization, and Clinical Outcomes: Evidence from Neonatology<\/p>\n

Nov 2
\nVincent Pohl
\nEvaluation of the Medicare Care Choices Model<\/p>\n

Nov 9
\nAugustine Denteh
\nWho Increases Emergency Department Use? New Insights from the Oregon Health Insurance Experiment<\/p>\n

Nov 16
\nDan Zeltzer \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 T
\nhe Impact of Increased Access to Telemedicine<\/p>\n

Nov 30
\nDonghoon Lee
\nDo for-profit hospitals cream-skim patients?\u00a0Evidence from inpatient psychiatric care in California<\/p>\n

Dec 7
\nManasvini Singh
\nHow Power Shapes Behavior: Evidence from Physicians<\/p>\n<\/div>\n

\nJan 6
\nYingying Dong<\/strong>
\nRegression Discontinuity Designs with a Continuous Treatment<\/em><\/p>\n

Jan 13
\nJill Furzer<\/strong>
\nDiagnostic errors in child mental health: Assessing treatment selection and its long-term consequences<\/em><\/p>\n

Jan 20
\nKelly Anderson<\/strong>
\nWhite and Brown Bagging of Physician-Administered Drugs in Medicare: Uptake and Implications for Spending and Patient Access<\/em><\/p>\n

Jan 27
\nElaine Liu<\/strong>
\nMalleability in Alcohol Consumption: Evidence from Migrants<\/em><\/p>\n

Feb 3
\nAlice Ellyson<\/strong>
\nSexual violence reporting among college athletes: A discrete choice experiment<\/em><\/p>\n

Feb 10
\nSindana Ilango<\/strong>
\nThe effect of local-level policies on air pollution and health in aging populations<\/em><\/p>\n

Feb 17
\nNoah Hammarlund<\/strong>
\nDecomposing racial disparities in prostate cancer treatment<\/em><\/p>\n

Feb 24
\nRebecca Myerson<\/strong>
\nFinding the Missing Enrollees: The Impact of Personalized Assistance on Health Insurance Uptake<\/em><\/p>\n

Mar 3
\nStacie Dusetzina<\/strong>
\nDrug Prices and Access to Medications in Medicare Part D<\/em><\/p>\n

Mar 10
\nBianca Frogner<\/strong>
\nEntry and exit patterns of health care workers during COVID<\/em><\/p>\n

Mar 31
\nSamin Jalali <\/strong>
\nHeterogeneities in Medicaid Effect: Evidence from Oregon Health Insurance Experiment<\/em><\/p>\n

Apr 7
\nMonica Aswani<\/strong>
\nMeasurement Error in the Hospital Readmission Reduction Program<\/em><\/p>\n

Apr 14
\nMaura Coughlin<\/strong>
\nRegional and Demographic Heterogeneity in Consideration in Medicare Part D Plan Choice<\/em><\/p>\n

Apr 21
\nStacie Dusetzina<\/strong>
\nDrug prices and access to medications in Medicare Part D<\/em><\/p>\n

Apr 28
\nPeter Hull<\/strong>
\nThe mortality effects of Medicare advantage plans<\/em><\/p>\n

May 5
\nPedro H.C. Sant\u2019Anna<\/strong>
\nDifference-in-Differences with multiple time periods<\/em><\/p>\n

May 12
\nJonathan Roth<\/strong>
\nWhen Is Parallel Trends Sensitive to Functional Form?<\/em><\/p>\n

May 19
\nNoah Simon<\/strong>
\nEffect-size estimation in high dimensional problems<\/em><\/p>\n

May 26
\nEdward Kennedy<\/strong>
\nRobust causal inference with continuous instruments using the local instrumental variable curve<\/em><\/p>\n

Sep 29
\nAaron Kesselheim and William Feldman<\/strong>
\nEstimating Rebates in Studies of Medicare Drug Pricing<\/em><\/p>\n

Oct 13
\nMelissa Knox<\/strong>
\nEmployment Quality and Health Behaviors during COVID-19<\/em><\/p>\n

Oct 20
\nChad Meyerhoefer<\/strong>
\nDo Elections Make You Sick? Evidence from First-Time Voters<\/em><\/p>\n

Oct 27
\nErin Trish<\/strong>
\nRedesigning Medicare Part D<\/em><\/p>\n

Nov 3
\nNathaniel Hendrix<\/strong>
\nRadiologist Preferences for Implementation of Artificial Intelligence-Based Clinical Decision Support and Risk Prediction<\/em><\/p>\n

Nov 10
\nJob Market Talk<\/em><\/p>\n

Nov 17
\nMeng Li <\/strong>
\nCompetition, drug characteristics, and rebate of branded prescription drugs<\/em><\/p>\n

Dec 8
\nNeil Jay Sehgal <\/strong>
\nGender differences in salary among internal medicine physicians at five academic medical centers in California<\/em><\/p>\n<\/div>\n

\nJan 15, 2020
\nGreg Guzauskas<\/strong>
\nCost-effectiveness of Oral Semaglutide for Type 2 Diabetes: An ICER Microsimulation Model<\/em><\/p>\n

Jan 22, 2020
\nBetty Bekemeier<\/strong>
\nA Uniform Chart of Accounts for Public Health: Finally measuring Public Health investments in the United States<\/em><\/p>\n

Jan 29, 2020
\nAnirban Basu<\/strong>
\nFinding Value: Pending Reforms to Prescription Drug Pricing in the United States<\/em><\/p>\n

Feb 5, 2020
\nLauren Strand<\/strong>
\nRecreational cannabis sales and opioid dispensing: a county-level analysis in Washington State 2014-2018<\/em><\/p>\n

Feb 12, 2020
\nAlice Ellyson<\/strong>
\nThe effect of PDMPs on opioid prescribing behavior among the elderly<\/em><\/p>\n

Feb 19, 2020
\nEmily Williams<\/strong>
\nImplementing care for opioid use disorders in VA primary care: an operationally partnered effort<\/em><\/p>\n

Feb 26, 2020
\nWei-Jhih Wang<\/strong>
\nMimicking Clinical Trials Using Real-World Data \u2013 A Novel Method and Applications<\/em><\/p>\n

Mar 4, 2020
\nCharles Phelps<\/strong>
\nAdvances in Cost-Effectiveness-Analysis Methods<\/em><\/p>\n

Apr 1, 2020
\nLauren Olsho <\/strong>
\nReducing Early Childhood Obesity: Impacts of Efforts to Improve Nutrition and Physical Activity in Los Angeles County, California<\/em><\/p>\n

Apr 8, 2020
\nKate Johnson<\/strong>
\nCost-Effectiveness of Case Detection Strategies for the Early Detection of COPD<\/em><\/p>\n

Apr 22, 2020
\nShuxian Chen<\/strong>
\nMarket dynamics with respect to more generic drug competition<\/em><\/p>\n

Apr 29, 2020
\nTracy Mroz<\/strong>
\nVariation in Employment of Therapy Assistants in Skilled Nursing Facilities Based on Organizational Factors<\/em><\/p>\n

May 6, 2020
\nJessica Jones-Smith and Kelsey Kinderknecht<\/strong>
\nWas the Healthy Hunger Free Kids Act of 2010 successful in improving diet quality for lower-income children? Evidence from the National Health and Nutrition Examination Survey<\/em><\/p>\n

May 13, 2020
\nDiana Poehler<\/strong>
\nDeveloping a Multi-Criteria Decision Analysis ( MCDA) in the Context of Critical Limb Ischemia: Challenges and Solutions<\/em><\/p>\n

Oct 7, 2020
\nErin Morgan<\/strong>
\nState Earned Income Tax Credits: Anti-Poverty Policy and Health<\/em><\/p>\n

Oct 14, 2020
\nLuis Diego Granera<\/strong>
\nPrimary healthcare access and its effects on standard of living: evidence from Costa Rica<\/em><\/p>\n

Oct 21, 2020
\nMark Fendrick<\/strong>
\nTurning the COVID-19 Crisis into Opportunity: Using Value-Based Insurance Design to Increase Use of High-value Care and Eliminate Low Value Services<\/em><\/p>\n

Oct 28, 2020
\nKosali Simon<\/strong>
\nEffects of State COVID-19 Closure Policy on NON-COVID-19 Health Care Utilization<\/em><\/p>\n

Nov 4, 2020
\nMarcia Weaver<\/strong>
\nHealth spending efficiency in the United States: Cause-Specific Health Spending per Disability-Adjusted Life-Year Averted from 1996 to 2016<\/em><\/p>\n

Nov 18, 2020
\nJinyi Zhu<\/strong>
\nEvaluating bias and variance across different validation methods of simulation models<\/em><\/p>\n

Dec 2, 2020
\nMelissa Knox<\/strong>
\nDoes early childhood access to health insurance affect schooling in Mexico?<\/em><\/p>\n

Dec 9, 2020
\nBeth Devine & Enrique Saldarriaga<\/strong>
\nAssessment of Payers\u2019 Preferences for Real World Evidence: A Discrete Choice Experiment<\/em><\/p>\n<\/div>\n

\nJan 9, 2019
\nNoah Hammarlund<\/strong>
\nDiagnosing Clinical Treatment Disparities with Machine Learning-Based Decomposition<\/em><\/p>\n

Jan 16, 2019
\nFahad Khalil<\/strong>
\nCompetitive Procurement with Ex Post Moral Hazard<\/em><\/p>\n

Jan 23, 2019
\nMarcia Weaver<\/strong>
\nFunding and services needed to achieve universal health coverage: applications of global, regional, and national estimates of utilization of outpatient visits and inpatient admissions from 1990 to 2016, and unit costs from 1995 to 2016<\/em><\/p>\n

Jan 30, 2019
\nKangho Suh<\/strong>
\nExploring heterogeneity in effectiveness and safety of newer P2Y12 inhibitors vs. clopidogrel in acute coronary syndrome patients<\/em><\/p>\n

Feb 6, 2019
\nJordan Banks<\/strong>
\nFinal Proposal for the Exploration of HealthCoin: A Currency to Address Potential Underfunding by Commercial Payers for Single or Limited Administration Treatments with Long-Term Efficacy<\/em><\/p>\n

Feb 13, 2019
\nJessica Jones-Smith<\/strong>
\nDid Seattle\u2019s Excise Tax on Sweetened Beverages Get Passed Through to Customers?<\/em><\/p>\n

Feb 20, 2019
\nBianca Frogner<\/strong>
\nAccessing Physical Therapy: A National Look at the Diagnosing Provider on Downstream Opioid Use<\/em><\/p>\n

Feb 27, 2019
\nKate Lofgren, Harvard University<\/strong>
\nVOI for Clinicians and Funders: An Accessible Approach to Value Research Aims<\/em><\/p>\n

Mar 6, 2019
\nKritee Gujral<\/strong>
\nThe impact of hospital closures on surrounding hospitals’ patient outcomes<\/em><\/p>\n

Mar 13, 2019
\nChuck Phelps, Au: Health Economics<\/strong>
\nTHE CHOICE INSTITUTE ANNUAL SYMPOSIUM \u2013 \u201cBeyond Cost-Effectiveness \u2013 Incorporating and Summarizing Multiple Dimensions of Value in Healthcare Technology Assessment\u201d<\/em><\/p>\n

Apr 3, 2019
\nAnkur Pandya<\/strong>
\nModeling the Cost Effectiveness of Two Big League Pay-for-Performance Policies<\/em><\/p>\n

Apr 10, 2019
\nNoah Hammarlund<\/strong>
\nRacial Treatment Disparities after Machine Learning Surgery-Appropriateness Adjustment<\/em><\/p>\n

Apr 17, 2019
\nAllison Portnoy <\/strong>
\nHealth Gains and Financial Protection from Human Papillomavirus (HPV) Vaccination in Ethiopia<\/em><\/p>\n

Apr 24, 2019
\nAnirban Basu<\/strong>
\nA Health Objective Function for Cost-Effectiveness Analysis Without the Baggage of QALYs<\/em><\/p>\n

May 1, 2019
\nEdwin Wong<\/strong>
\nEstimating Unmet VA Primary Care Using Econometric Disequilibrium Models<\/em><\/p>\n

May 8, 2019
\nAlex Woersching<\/strong>
\nDo Price Shopping Opportunities Justify the Hype Around Price Transparency?<\/em><\/p>\n

May 15, 2019
\nKai Yeung<\/strong>
\nImpact of Specialty Drug Out-Of-Pocket Cap Laws on Patient Financial Burden<\/em><\/p>\n

May 29, 2019
\nAigbokhai Unuigbe<\/strong>
\nThe Lifecycle of Generics<\/em><\/p>\n

June 5, 2019
\nKate Johnson<\/strong>
\nUnderstanding disease trajectory to guide precision policy: a case study in COPD<\/em><\/p>\n

Sept 25, 2019
\nKritee Gujral, PhD<\/strong>
\nImpact of Rural and Urban Hospital Closures on Inpatient Mortality<\/em><\/p>\n

Oct 16, 2019
\nMelissa Knox, PhD<\/strong>
\nFirm Behavior and the Incidence of Sin Taxes: Evidence from Seattle\u2019s Sweetened Beverage Tax<\/em><\/p>\n

Nov 6, 2019
\nKate Rosettie, MPH<\/strong>
\nMeta-regression analysis of HPV Vaccine Cost-Effectiveness<\/em><\/p>\n

Nov 13, 2019
\nBianca Frogner, PhD<\/strong>
\nWhere to Start? How the First Point of Care Provider Influences Low Back Pain Outcomes and Cost<\/em><\/p>\n

Dec 4, 2019
\nElizabeth Brouwer<\/strong>
\nEstimating the drug-specific price elasticity of demand for multiple sclerosis (MS) specialty medications in the Kaiser Permanente Washington system accounting for copay assistance<\/em><\/p>\n

Dec 11, 2019
\nLauren Strand<\/strong>
\nRecreational and medicinal cannabis sales and opioid dispensing: a county-level analysis in Washington State 2014-2017<\/em><\/p>\n<\/div>\n

\n

January 17, 2018
\nJevay Grooms<\/strong>
\nRace, Gender, and Opioid Treatment Admissions: The Effect of PDMPs on the Most Afflicted<\/em><\/p>\n

January 24, 2018
\nBianca Frogner<\/strong>
\nCommuting Patterns of Healthcare Workers<\/em><\/p>\n

January 31, 2018
\nCarol Levin<\/strong>
\nVoluntary Male Medical Circumcision (VMMC) \u00a0costs and unit costs from the Global Health Cost Consortium<\/em><\/p>\n

February 7, 2018
\nGang Luo<\/strong>
\nIdentifying Future High-Cost Patients for Care Management<\/em><\/p>\n

February 14, 2018
\nLiisa Laine<\/strong>
\nQuality and Competition between Public and Private Firms<\/em><\/p>\n

February 21, 2018
\nShan Liu<\/strong>
\nOptimizing dynamic decision-making: models and insights for chronic disease care<\/em><\/p>\n

February 28, 2018
\nMeng Li<\/strong>
\nThe real option value of life and innovation<\/em><\/p>\n

March 7, 2018
\nMark Bounthavong<\/strong>
\nProviders’ knowledge, attitude, and satisfaction with Academic Detailing in Opioid Overdose Education and Naloxone Distribution<\/em><\/p>\n

March 28, 2018
\nDomenico Depalo<\/strong>, Bank of Italy
\nExplaining the relation between pills and cholesterol through the marginal patient<\/em><\/p>\n

April 4, 2018
\nYates Coley<\/strong>, KPWHRI
\nEffectively communicating your research results using statistical graphics<\/em><\/p>\n

April 11, 2018
\nLiisa Laine<\/strong>
\nMarket-level effects of a Large-Scale School Choice Reform<\/em><\/p>\n

April 18, 2018
\nAmber Sabbatini<\/strong>
\nHospital observation stays: implications for costs and quality<\/em><\/p>\n

April 25, 2018
\nRagan Hart<\/strong>
\nUsing Real-World Pharmacogenetic Knowledge Resources to Guide Clinical Decision-Making<\/em><\/p>\n

May 2, 2018
\nPeter Neumann<\/strong>
\nSpecial Presentation ( jointly sponsored by HICOR, Fred Hutch)<\/em><\/p>\n

May 9, 2018
\nGuido Cataife<\/strong>, IMPAQ
\nGeneralization of the Difference-in-Differences Model for Applied Research<\/em><\/p>\n

May 16, 2018
\nAlice Ellyson<\/strong>
\nThe Economic and Clinical Impact of Washington state’s Oral Chemotherapy Parity Law<\/em><\/p>\n

March 28, 2018
\nDomenico Depalo<\/strong>, Bank of Italy
\nExplaining the relation between pills and cholesterol through the marginal patient<\/em><\/p>\n

April 4, 2018
\nYates Coley<\/strong>, KPWHRI
\nEffectively communicating your research results using statistical graphics<\/em><\/p>\n

April 11, 2018
\nLiisa Laine<\/strong>
\nMarket-level effects of a Large-Scale School Choice Reform<\/em><\/p>\n

April 18, 2018
\nAmber Sabbatini<\/strong>
\nHospital observation stays: implications for costs and quality<\/em><\/p>\n

April 25, 2018
\nRagan Hart<\/strong>
\nUsing Real-World Pharmacogenetic Knowledge Resources to Guide Clinical Decision-Making<\/em><\/p>\n

May 2, 2018
\nPeter Neumann<\/strong>
\nSpecial Presentation ( jointly sponsored by HICOR, Fred Hutch)<\/em><\/p>\n

May 9, 2018
\nGuido Cataife<\/strong>, IMPAQ
\nGeneralization of the Difference-in-Differences Model for Applied Research<\/em><\/p>\n

May 16, 2018
\nAlice Ellyson<\/strong>
\nThe Economic and Clinical Impact of Washington state’s Oral Chemotherapy Parity Law<\/em><\/p>\n

October 3, 2018
\nMelissa Knox<\/strong>
\nUniversal health care and chronic disease management: Exploring the role of health care reform in diagnosis and treatment for diabetes-related complications in Mexico<\/em><\/p>\n

October 10, 2018
\nDouglas Barthold<\/strong>
\nThe effects of state level pharmacist regulations on generic substitution of subscription drugs<\/em><\/p>\n

October 17, 2018
\nJoelle Abramowitz, University of Michigan<\/strong>
\nAccess to Assisted Reproductive Technology and Maternal Mortality<\/em><\/p>\n

October 24, 2018
\nJessica Jones-Smith<\/strong>
\nIncreased economic resources and childhood obesity: A quasi-experimental study<\/em><\/p>\n

November 7, 2018
\nSang-Eun Choi, Korea University<\/strong>
\nCurrent pharmaceutical policy and HTA from the Korean National Health Insurance perspective<\/em><\/p>\n

November 14, 2018
\nElizabeth Brouwer<\/strong>
\nExploring the shift to value-based formularies in private health insurance 2010-2013 and modeling their potential impact in the future<\/em><\/p>\n

November 28, 2018
\nCarrie Bennette, Flatiron Health<\/strong>
\nBuilding external control arms for clinical trials using real-world data: opportunities and challenges<\/em><\/p>\n

December 5, 2018
\nAnirban Basu<\/strong>
\nDoes current practice of evidence-based medicine breeds disparities?<\/em><\/p>\n<\/div>\n

\n1\/12\/2017
\nAmy Cizik<\/strong>, University of Washington
\nDeveloping Health State Vignettes for Estimating Health State Utility Values in Soft Tissue Sarcoma: Methods, Lessons, and Implications<\/em><\/p>\n

1\/19\/2017
\nJane Lange<\/strong>, Group Health Research Institute
\nA Framework for Treatment Decision Making at Prostate Cancer Recurrence<\/em><\/p>\n

1\/26\/2017
\nSungchul Park<\/strong>, University of Washington
\n Towards assessing individual-level prediction accuracy for healthcare expenditures: comparing alternative estimators for risk adjustment of payments to health plans<\/em><\/p>\n

2\/2\/2017
\nAlex Woershing<\/strong>, University of Washington
\n A Proposal for Evaluating a Campaign to Promote Use of a Price Estimator Web Tool for Clinical Services<\/em><\/p>\n

2\/09\/2017
\nBianca Frogner<\/strong>, University of Washington
\nDoes Medicare Managed Care Affect Diabetic Patient Cost, Use and Quality Associated with Different Medical Labor Inputs <\/em><\/p>\n

2\/16\/2017
\nM. Ragan Hart<\/strong>, University of Washington
\nProjected Cost-Effectiveness of an Array-Based Multi-Gene Pharmacogenetic (PGx) Testing Panel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention<\/em><\/p>\n

2\/23\/2017
\nAnobel Odisho<\/strong>, University of Washington
\nBeyond Classical Risk Adjustment: Socioeconomic Status and Hospital Performance in Urologic Oncology<\/em><\/p>\n

3\/2\/2017
\nNicholas Papageorge<\/strong>, Johns Hopkins University
\nInnovation and Diffusion of Medical Treatment<\/em><\/p>\n

3\/09\/2017
\nJoan Teno<\/strong>, University of Washington
\nTransparency and Accountability for Community Based Programs for High Cost, High Need Patients <\/em><\/p>\n

3\/30\/2017
\nLindsay White<\/strong>, University of Washington
\n Current costs of Alzheimer’s Care<\/em><\/p>\n

4\/06\/2017
\nAnkur Pandya<\/strong>, Harvard University
\nThe Arranged Marriage of Pay-for-Performance and Cost-Effectiveness Analysis in Acute Stroke Care<\/em><\/p>\n

4\/13\/2017
\nTheresa Hoeft<\/strong>, University of Washington
\nCosts when task-sharing depression care between clinic and community partners<\/em><\/p>\n

4\/20\/2017
\nMarcia Weaver<\/strong>, University of Washington
\n Health care utilization: a meta analyses of outpatient visits and inpatient admissions by age, gender for 188 countries from 1990-2015<\/em><\/p>\n

4\/27\/2017
\nSolomon Lubinga<\/strong>, University of Washington
\nPreferences for voluntary medical male circumcision services for HIV prevention: a discrete choice experiment among fisherfolk in central Uganda<\/em><\/p>\n

5\/04\/2017
\nJavay Grooms<\/strong>,University of Washington
\nState prevention interventions and opioid abuse<\/em><\/p>\n

5\/11\/2017
\nSeyed Karimi<\/strong>, University of Washington, Tacoma
\nPre-Birth Exposure to Ramadan, Height, and the Length of Gestation<\/em><\/p>\n

5\/18\/2017
\nSungchul Park<\/strong>, University of Washington
\nTheoretical and Empirical Analysis of Medicare Managed Care’s Response to Risk Adjustment<\/em><\/p>\n

6\/01\/2017
\nTricia Rodriguez<\/strong>, University of Washington
\nMinimizing Barriers to Retention on HIV Antiretroviral Therapy (ART): Results of Haiti’s “Multi-Month Scripting” (MMS) Initiative Extending Prescribing Intervals for ART Patients<\/em><\/p>\n

10\/4\/2017
\nAlice Ellyson<\/strong>
\nPharmaceutical pricing anticipating entry: the case for insulin<\/em><\/p>\n

10\/11\/2017
\nBadri Narayanan G.<\/strong>, McKinsey Global Institute and UW
\nR&D Expenditure, Productivity and Profitability: Evidence from Indian Pharmaceutical Industry<\/em><\/p>\n

10\/18\/2017
\nLisa Laine<\/strong>
\nEffects of a National Drug Monitoring Intervention on Prescription Drug Abuse<\/em><\/p>\n

11\/1\/2017
\nDavene Wright<\/strong>
\nFinancial incentives to promote engagement in family based childhood obesity treatment: development of a discrete choice experiment<\/em><\/p>\n

11\/8\/2017
\nPaul Fishman<\/strong>
\nMeasuring Physician Productivity for Efficient Management of Primary Care Panels<\/em><\/p>\n

11\/15\/2017
\nJosh Carlson<\/strong>
\nA Pilot Study Integrating Value of Research Analyses into NCI Clinical Trials Cooperative Group Research Review and Prioritization<\/em><\/p>\n

11\/29\/2017
\nJosh Liao<\/strong>
\nThe Value Proposition of Bundled Payment: National and Local Perspectives<\/em><\/p>\n

12\/6\/2017
\nNina Joyce<\/strong>, Brown University
\nThe Impact of Dementia Special Care Units on Quality of Care: An Instrumental Variables Approach<\/em>\n<\/div>\n

\n01\/07\/2016
\nMuxin Zhai<\/strong>, Department of Economics, University of Washington
\n The impact of maternal exposure to air pollution on infant health.<\/em><\/p>\n

01\/14\/2016
\nPeter Zweifel<\/strong>, University of Zurich, Zurich
\nWillingness-to-Pay for a New Pharmaceutical: Is It Worth the Money? Whose Money?
\n<\/em><\/p>\n

01\/21\/2016
\nDavid Kim<\/strong>, Department of Health Services, University of Washington
\nNew Metrics for Economic Evaluation in the Presence of Heterogeneity: Focusing on evaluating policy alternatives rather than treatment alternatives<\/em><\/p>\n

01\/28\/2016
\nBrian Dillon<\/strong>, Evans School of Public Policy and Governance, University of Washington
\nLong-Term Consequences of Consumption Seasonality<\/em><\/p>\n

02\/04\/2016
\nAmy Cizik<\/strong>, PORPP, University of Washington
\nA Markovian cost Utility Model for Soft Tissue Sarcoma<\/em><\/p>\n

02\/11\/2016
\nCarol Levin1<\/sup> and Suzanne Kerns2<\/sup><\/strong>, 1<\/sup>Department of Global Health and 2<\/sup>Department of Psychiatry and Behavioral Sciences, University of Washington
\nIncluding implementation stages in evaluating the costs of mental health interventions: A case study of scaling up evidence based practices in Washington State<\/em><\/p>\n

02\/18\/2016
\nBianca Frogner<\/strong>, Department of Family Medicine, University of Washington
\nDoes unrestricted direct access to physical therapy impact health spending?<\/em><\/p>\n

02\/25\/2016
\nAnirban Basu<\/strong>, PORPP, University of Washington Estimating Price Elasticities from a Value-based Formulary Implementation<\/em><\/p>\n

03\/03\/2016
\nGuido Cataife<\/strong>, IMPAQ International, LLC
\nHow much health does a dollar buy? The effect of health care spending on age-adjusted mortality in the US<\/em><\/p>\n

03\/10\/2016
\nKai Yeung<\/strong>, PROPP, University of Washington
\n Assessing stakeholder experiences and attitudes regarding cures<\/em><\/p>\n

4\/06\/2016
\nSPECIAL JOINT SEMINAR WITH PORPP<\/strong>
\nWEDNESDAY 12:00-1:00 in SOCC 303<\/strong>
\nAnkur Pandya<\/strong>, Harvard University
\n Statins, Value and Values<\/em><\/p>\n

4\/14\/2016
\nBen Ely<\/strong>, University of Washington, Department of Health Services
\nA policy evaluation of the CDC’s campaign: Get Smart about Antibiotics<\/em><\/p>\n

4\/21\/2016
\nSherry Willis<\/strong>, University of Washington, Department of Psychiatry and Behavioral Sciences
\n Seattle Longitudinal Study: Current Findings and Future Research Possibilities<\/em><\/p>\n

5\/05\/2016
\nErin Vernon<\/strong>, Seattle University, Economics Department
\nIs Ignorance Bliss? A Systematic Review of Economic Evaluations of Thrombophilia Screening prior to Combined Hormonal Contraceptive Use<\/em><\/p>\n

5\/12\/2016
\nCarrie Bennette<\/strong>, University of Washington, PORPP
\nEvaluating pharmaceutical innovation in the expanding market for oral chemotherapy<\/em><\/p>\n

5\/19\/2016
\nSouvik Banerjee<\/strong>,University of Washington, PORPP
\nIdentifying endogenous treatment effects using latent factor models<\/em><\/p>\n

5\/26\/2016
\nCarol Levin<\/strong>,University of Washington, Global Health
\nImproving the Efficiency in HIV and TB: Overview of the Global Health Cost Consortium<\/em><\/p>\n

10\/06\/2016
\nJohn Dickerson<\/strong>, Kaiser Permanente, Center for Health Research
\nUse of dose-response in clinical trials: challenges and opportunities<\/em><\/p>\n

10\/13\/2016
\nAnupam Jena<\/strong>, Havard University
\nMarathons and Mortality<\/em><\/p>\n

10\/20\/2016
\nMelissa Rosen<\/strong>, University of Washington
\n Changing Medicare Part D Prescription Drug Plans: Estimating the Effects of Plan Switching on under-65 Dual Eligible<\/em><\/p>\n

11\/10\/2016
\nEdwin Wong <\/strong>, University of Washington and VA Affairs
\nMassachusetts Health Reform and Dual Use of VA and non-VA Outpatient Services<\/em><\/p>\n

11\/17\/2016
\nBen Ely<\/strong>,University of Washington
\nEvaluation of CDC’s Get Smart Program on Appropriate Antibiotics Use<\/em><\/p>\n

12\/01\/2016
\nTiffany Radcliff<\/strong>, Texas A&M University
\nPrice Searching in the Health Insurance Exchange<\/em><\/p>\n

12\/08\/2016
\nMelissa Knox<\/strong>, University of Washington
\nMoral Hazard and Universal Health Care<\/em>\n<\/div>\n

\n01\/14\/2015
\nScott Emerson<\/strong>, University of Washington
\n Methods Topic: Clinical trials <\/strong>Bayesian and Frequentist Inference Following Adaptive Trial Design<\/em><\/p>\n

01\/21\/2015
\nSusan Shortreed<\/strong>,Group Health Research Institute
\nMethods Topic: Dynamic Treatments<\/strong> Constructing Optimal Dynamic Antipsychotic Treatment Regimes for Patients with Schizophrenia<\/em><\/p>\n

01\/28\/2015
\nAbraham Flaxman<\/strong>, Institute for Health Metrics and Evaluation
\nMethods Topic: Meta-Regression<\/strong> The Integrative Meta-regression Framework from the Global Burden of Disease (DisMod-MR)<\/em><\/p>\n

02\/04\/2015
\nRuth Etzioni<\/strong>,Fred Hutchinson Cancer Research Center
\nMethods Topic: Simulation Modeling<\/strong> Simulation modeling as a tool for comparative effectiveness: an overview illustrated by examples from cancer research<\/em><\/p>\n

02\/10\/2015
\nMark Sculpher<\/strong>, University of York, UK
\nHealth Sciences Turner Auditorium, D-209<\/strong> Is NICE doing more harm than good to population health?<\/a><\/em><\/p>\n

02\/11\/2015
\nAli Shojaie<\/strong>, University of Washington
\nMethods Topic: Machine Learning<\/strong> How reliable are our models in high dimensions?<\/em><\/p>\n

02\/18\/2015
\nCarrie Bennette<\/strong>, University of Washington
\nMethods Topic: Value of Information<\/strong> Minimal Modeling Value of Information Analyses for Prioritization Decisions within a Cancer Clinical Trials Cooperative Group<\/em><\/p>\n

02\/25\/2015
\nHolly Janes<\/strong>, Fred Hutchinson Cancer Research Center
\nMethods Topic: Treatment Effect Heterogeneity (Biomarker Evaluation)<\/strong> An overview of current methodology for designing and analyzing clinical trials evaluating biomarkers for predicting treatment effect<\/em><\/p>\n

03\/04\/2014
\nDonald Hedeker<\/strong>,University of Chicago, IL
\nMethods Topic: Intensive Longitudinal Data<\/strong> Modeling between and within-subject variances using mixed effects location scale models for intensive longitudinal data<\/em><\/p>\n

03\/11\/2015
\nAnirban Basu<\/strong>, University of Washington
\nMethods Topic: Instrumental Variables and Heterogeneity<\/strong> Understanding identification in instrumental variables methods and its application in comparative effectiveness research<\/em><\/p>\n

04\/08\/2015
\nSarah Beth Barnett<\/strong>, University of Washington
\nMassachusetts health reform: financial and mental health effects<\/em><\/p>\n

04\/15\/2015
\nPierre Thomas L\u00e9<\/strong>, HEC Montreal, Canada
\n Physician Practice Style and Healthcare Costs: Evidence from Emergency Departments<\/em><\/p>\n

04\/22\/2015
\nBianca Frogner<\/strong>, University of Washington
\nHealth Care Workforce Trends<\/em><\/p>\n

04\/29\/2015
\nKai Yeung<\/strong>,University of Washington
\n Application of Cost-Effectiveness Logic to US Managed Care Drug Formularies: Long term Outcomes of a Value-based Formulary<\/em><\/p>\n

05\/06\/2015
\nZachary Marcum<\/strong>, University of Washington
\nMedicare Part D: A Tale of Two Analyses<\/em><\/p>\n

05\/13\/2015
\nTamara Konetzka<\/strong>, University of Chicago, IL
\nEffects of Malpractice Litigation on Nursing Home Ownership Change and Exit<\/em><\/p>\n

05\/20\/2014
\nBenjamin Ely<\/strong>,University of Washington
\nAcute bronchitis and patterns of antibiotic use<\/em><\/p>\n

05\/27\/2015
\nAnirban Basu<\/strong>, University of Washington
\n 2SLS vs 2SRI: Appropriate methods for rare outcomes and\/or rare exposures<\/em><\/p>\n

10\/01\/2015
\nSouvik Banerjee<\/strong>, University of Washington
\n An Analysis of the Effect of Psychiatric Disorders on Probation Outcomes and Prison Entry among Probationers in New York State<\/em><\/p>\n

10\/08\/2015
\nRuth Etzioni<\/strong>, University of Washington and Fred Hutch
\nLimitations of Screening Trials in Developing Cancer Screening Policies<\/em><\/p>\n

10\/15\/2015
\nAnirban Basu and Norma Coe<\/strong>, University of Washington
\n Potential R01s: Where can we collaborate?<\/em><\/p>\n

10\/22\/2015
\nAmy Cizik<\/strong>, University of Washington
\nVariations in Surgeon Treatment Preferences for Soft Tissue Sarcoma: Chronic vs. Temporary Health State Utility Calculations<\/em><\/p>\n

10\/29\/2015
\nNorma Coe<\/strong>,University of Washington
\n Assisted Living Communities’ Impact on Nursing Homes<\/em><\/p>\n

11\/05\/2015
\nBianca Frogner<\/strong>, University of Washington
\nLow-wage and Low-skilled Health Care Workers<\/em><\/p>\n

11\/12\/2015
\nDavene Wright<\/strong>, University of Washington and Seattle Children’s
\nHardwired for Hope: Measuring Parental Optimism Bias around Childhood Obesity-Related Outcomes<\/em><\/p>\n

11\/19\/2015
\nCarrie Bennett<\/strong>,University of Washington
\nEvaluating trends in cancer drug prices<\/em><\/p>\n

12\/03\/2015
\nJoan Teno<\/strong>, University of Washington
\n Post acute care and Health Care Reform: Wild, Wild, Wet<\/em><\/p>\n<\/div>\n

\n1\/9\/2014
\nMarcia Weaver<\/strong>, Department of Global Health, University of Washington
\nIntegrated infectious disease training and on-site support in Uganda: Design and preliminary results for a cost-effectiveness analysis<\/em><\/p>\n

1\/16\/2014
\nStephane Verguet<\/strong>, Department of Global Health, University of Washington
\nUniversal health coverage & efficient provision of financial risk protection<\/a><\/em><\/p>\n

1\/23\/2014
\nLin-Chi Hsu<\/strong>, Department of Economics, University of Washington
\nThe Timing of Welfare Payments and Domestic Violence<\/em><\/p>\n

2\/6\/2014
\nCarol Levin<\/strong>, Department of Global Health, University of Washington
\nA new Global Investment Framework for Women\u2019s and Children\u2019s Health<\/em><\/p>\n

2\/20\/2014
\nNathan Tefft<\/strong>, Department of Health Services, University of Washington
\nFinancial Conflicts of Interest in Medicine<\/em><\/p>\n

2\/27\/2014
\nAnupam Jena<\/strong>, Department of Health Care Policy, Harvard Medical School
\nMortality among patients hospitalized with acute cardiovascular conditions during dates of national cardiology meetings<\/em><\/p>\n

3\/6\/2014
\nSarah Taubman<\/strong>, Department of Health Services, University of Washington
\nRecent results from the Oregon Health Insurance Experiment: Emergency department use and labor market activity<\/em><\/p>\n

3\/13\/2014
\nSamuel Henly<\/strong>, Department of Economics, University of Washington
\nSex Workers, Job Lock, and the Affordable Care Act<\/em><\/p>\n

4\/10\/2014
\nRosa Avila<\/strong>, Department of Health Services, University of Washington
\nThe Massachusetts Health Reform and Children’s Health: Can We Achieve Health and Health Care Equity among All Children?<\/em><\/p>\n

4\/24\/2014
\nZachary Olson and John Staples<\/strong>, Department of Global Health, University of Washington
\nHelmet Regulation in Vietnam: An Extended Cost-Effectiveness Analysis<\/em><\/p>\n

5\/1\/2014
\nJohn Dickerson<\/strong>, Department of Health Services, University of Washington
\nMedication Adherence through Industry-Level Business Cycles: an Application of the Economic Stress Hypothesis<\/em><\/p>\n

5\/8\/2014
\nJoshua Roth<\/strong>, Fred Hutchinson Cancer Research Center
\nEconomic Return from the Women\u2019s Health Initiative Estrogen plus Progestin Clinical Trial<\/em><\/p>\n

5\/15\/2014
\nSteven Zeliadt<\/strong>, Department of Health Services, University of Washington
\nTranslating lung cancer screening from the trial setting into clinical practice at VA<\/em><\/p>\n

5\/22\/2014
\nJustin Robertson<\/strong>, Department of Economics, University of Washington
\nAre Physicians Learning? Using Person-Centered Treatment Effects to Evaluate Learning Among Medicaid Patients with Schizophrenia<\/em><\/p>\n

5\/29\/2014
\nAndrew J. Brunskill<\/strong>, Departments of Epidemiology and Health Services, University of Washington
\nWhat is different about smoking in pregnancy : Psychology, physiology and economics<\/em><\/p>\n

6\/5\/2014
\nNorma Coe<\/strong>, Department of Health Services, University of Washington
\nIs There Intra-Family Moral Hazard in Long-Term Care?<\/em><\/p>\n

10\/1\/2014<\/p>\n

Davene R. Wright<\/strong>, Seattle Children’s Research Institute
\nImproving parental engagement in obesity interventions through risk communication<\/em><\/p>\n

10\/8\/2014
\nEdwin S. Wong<\/strong>,VA Puget Sound Health Care System<\/p>\n

10\/15\/2014
\nDavid D. Kim<\/strong>,Department of Health Services
\nLong term cost-effectiveness of alcohol-use disorder; PDP review<\/em><\/p>\n

10\/22\/2014
\nJustin Robertson<\/strong>,Department of Health Services
\nOptimal Insurance Contracts with Patients and Payment Contracts with Medical Providers when Threat of Waiving Copayments Exists<\/em><\/p>\n

10\/29\/2014
\nSouvik Banerjee<\/strong>, Pharmaceutical Outcomes Research and Policy Program<\/p>\n<\/div>\n

\n1\/10\/2013
\nSteve Zeliadt<\/strong>, University of Washington
\nPotential Pathways for Containing Costs of Lung Cancer Screening for VHA<\/em><\/p>\n

1\/17\/2013
\nBenjamin Hansen<\/strong>, University of Oregon
\nMedical Marijuana Laws and Teen Drug Use<\/a><\/em><\/p>\n

1\/31\/2013
\nJoe Dieleman<\/strong>, University of Washington
\nMeasuring the displacement and replacement of development assistance for health<\/em><\/p>\n

2\/7\/2013
\nNathan Tefft<\/strong>, University of Washington
\nThe Dow is Killing Me: Risky Health Behaviors and the Stock Market<\/em><\/p>\n

2\/21\/2013
\nDavene Wright<\/strong>, University of Washington
\nThe Cost-Effectiveness of Screening U.S. Adolescents for Eating Disorders<\/em><\/p>\n

2\/28\/2013
\nShamma Alam<\/strong>, University of Washington
\nHow Does Parental Illness Affect Children? Impact of Parental Health Shocks on Child Labor and Education in Tanzania<\/em><\/p>\n

3\/7\/2013
\nNorma Coe<\/strong>, University of Washington
\nDisability and Labor Supply: The Role of Health Insurance<\/em><\/p>\n

3\/14\/2013
\nAnirban Basu<\/strong>, University of Washington
\nLong-Term Health Returns to Quality of Schooling: the Roles of Selection and Heterogeneity<\/em><\/p>\n

4\/4\/2013
\nRuth Etzioni<\/strong>, University of Washington
\nMeasuring Overdiagnosis in Breast and Prostate Cancer Screening: Overcoming Challenges, Avoiding Mistakes<\/em><\/p>\n

4\/11\/2013
\nFahad Khalil<\/strong>, University of Washington
\nContracts offered by Bureaucrats<\/em><\/p>\n

4\/18\/2013
\nCharles Manski<\/strong>, Northwestern University
\nTwo Problems in Medical Decision Making under Ambiguity<\/em><\/p>\n

4\/25\/2013
\nCarol Levin<\/strong>, University of Washington
\nUsing cost analysis to better design global health interventions: Lessons from HPV vaccination in Peru, Uganda, India and Vietnam<\/em><\/p>\n

5\/2\/2013
\nChristopher Auld<\/strong>, University of Victoria
\nMinimum pricing of alcohol: Theory and evidence<\/em><\/p>\n

5\/9\/2013
\nJulia Slejko<\/strong>, University of Washington
\nUsing Latent Class Probability Estimation and Residual Inclusion to Address Confounding in Medication Adherence Modeling<\/em><\/p>\n

5\/16\/2013
\nAmitabh Chandra<\/strong>, Harvard University
\nTechnology Growth and Expenditure Growth in Health Care<\/em><\/p>\n

5\/23\/2013
\nMark Long<\/strong>, University of Washington
\nAn Altruism Adjusted Measure of the Value of a Statistical Life<\/em><\/p>\n

5\/30\/2013
\nSarah Taubman<\/strong>, University of Washington
\nThe Oregon Health Insurance Experiment: Evidence from the First Two Years<\/em><\/p>\n

9\/26\/2013
\nMichael Hanlon<\/strong>, Institute for Health Metrics and Evaluation, University of Washington
\nDevelopment Assistance for Health: Its allocation and impact on population health<\/em><\/p>\n

10\/10\/2013
\nShamma Alam<\/strong>, Department of Economics, University of Washington
\nParental Health Shocks, Child Labor and Educational Outcomes: Evidence from Tanzania<\/em><\/p>\n

10\/17\/2013
\nSarit Weisburd<\/strong>, Departments of Economics, The Hebrew University & University of Washington
\nDoes Police Presence Reduce Car Accidents?<\/a><\/em><\/p>\n

10\/24\/2013
\nKathleen Mullen<\/strong>, RAND Corporation
\nDisability Insurance and Healthcare Reform: Evidence from Massachusetts<\/em><\/p>\n

11\/7\/2013
\nJoseph Dieleman<\/strong>, Institute for Health Metrics and Evaluation, University of Washington
\nA combination of effects: how economic development, development assistance, democratization and government health spending affect under-five mortality<\/em><\/p>\n

11\/14\/2013
\nNorma Coe<\/strong>, Department of Health Services, University of Washington
\nOvercoming Barriers to Life Insurance Coverage: A Behavioral Approach<\/em><\/p>\n

12\/5\/2013
\nArati Dahal<\/strong>, Department of Health Services, University of Washington
\nThe Role of Health on Giving<\/em><\/p>\n<\/div>\n

\n10\/4\/2012
\nDamian Walker<\/strong>, Bill and Melinda Gates Foundation (flyer<\/strong><\/a>)
\nThe Portfolio Management Pilot: Developing a standard methodology for determining the potential risk and return of products in the Bill & Melinda Gates Foundation Global Health’s investment portfolio<\/em><\/p>\n

10\/11\/2012
\nRobert Penfold<\/strong>, Group Health Research Institute
\nCumulative Total Charges for Care Among Breast, Colorectal, and Lung Cancer Patients in the Oncology Nurse Navigator Trial<\/em><\/p>\n

10\/18\/2012
\nRachel Nugent<\/strong>, University of Washington
\nHow Does Chronic Disease Control Stack Up Among Economics Nobel Laureates?<\/a><\/em>
\nValue of Information Experiment Results<\/a><\/p>\n

10\/24\/2012*
\nAndy Willan<\/strong>, University of Toronto \u00a0 (*Joint with CHASE WIP – special Wed. session)
\nValue and Uncertainty in the Pricing New Health Care Interventions<\/em>\u00a0(details<\/strong><\/a>)<\/p>\n

11\/1\/2012
\nSean Sullivan<\/strong>, University of Washington
\nFinancial Risk-Sharing Agreements as a Mechanism for Market Access to Health Technology in Low to Middle Income Countries<\/em><\/p>\n

11\/8\/2012
\nJoelle Abramowitz<\/strong>, University of Washington
\nAssisted Reproductive Technology and Women’s Marriage and Birth Timing: Survival and Competing Risks Analyses.<\/a><\/em><\/p>\n

11\/15\/2012
\nDoug Conrad<\/strong>, University of Washington<\/p>\n

11\/29\/2012
\nSantosh Kumar<\/strong>, Institute for Health Metrics and Evaluation
\nGeographic constraint to institutional delivery in rural India: An instrumental variable approach<\/em><\/p>\n

12\/6\/2012
\nDavid Meltzer<\/strong>, University of Chicago
\nRedesign of Care for Patients at High Risk of Hospitalization in a Reforming U.S. Healthcare System: Rationale for a CMMI Innovation Challenge Project<\/em>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The Program in Health Economics and Outcomes Research Methodology (PHEnOM) at The CHOICE Institute is a joint program with the Department of Health Systems & Population Health in the School of Public Health at the…<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":18475,"menu_order":11,"comment_status":"closed","ping_status":"closed","template":"templates\/template-choice-institute.php","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-18477","page","type-page","status-publish","hentry"],"yoast_head":"\nProgram in Health Economics and Outcomes Research Methodology (PHEnOM) - School of Pharmacy<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Program in Health Economics and Outcomes Research Methodology (PHEnOM) - School of Pharmacy\" \/>\n<meta property=\"og:description\" content=\"The Program in Health Economics and Outcomes Research Methodology (PHEnOM) at The CHOICE Institute is a joint program with the Department of Health Systems & Population Health in the School of Public Health at the...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/\" \/>\n<meta property=\"og:site_name\" content=\"School of Pharmacy\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/UWSOP\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-04T23:01:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/sop.washington.edu\/wp-content\/uploads\/Doug-Barthold_sq-300x300.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@UW_Pharmacy\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"30 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/programs\\\/phenom\\\/\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/programs\\\/phenom\\\/\",\"name\":\"Program in Health Economics and Outcomes Research Methodology (PHEnOM) - School of Pharmacy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/programs\\\/phenom\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/programs\\\/phenom\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/Doug-Barthold_sq-300x300.jpg\",\"datePublished\":\"2017-12-04T18:55:02+00:00\",\"dateModified\":\"2026-05-04T23:01:54+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/programs\\\/phenom\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/programs\\\/phenom\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/programs\\\/phenom\\\/#primaryimage\",\"url\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/Doug-Barthold_sq-300x300.jpg\",\"contentUrl\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/Doug-Barthold_sq-300x300.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/programs\\\/phenom\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Research\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Programs\",\"item\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/choice\\\/research\\\/programs\\\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"Program in Health Economics and Outcomes Research Methodology (PHEnOM)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#website\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"name\":\"University of Washington School of Pharmacy\",\"description\":\"University of Washington\",\"publisher\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\"},\"alternateName\":\"UW School of Pharmacy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#organization\",\"name\":\"University of Washington School of Pharmacy\",\"alternateName\":\"UW School of Pharmacy\",\"url\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"contentUrl\":\"https:\\\/\\\/sop.washington.edu\\\/wp-content\\\/uploads\\\/W-Logo.png\",\"width\":526,\"height\":527,\"caption\":\"University of Washington School of Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/staff.washington.edu\\\/twentzel\\\/wordpress\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"http:\\\/\\\/www.facebook.com\\\/UWSOP\",\"https:\\\/\\\/x.com\\\/UW_Pharmacy\",\"https:\\\/\\\/www.instagram.com\\\/uw_pharmacy\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/UWPharmacySchool\",\"https:\\\/\\\/www.linkedin.com\\\/groups\\\/3820716\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Program in Health Economics and Outcomes Research Methodology (PHEnOM) - School of Pharmacy","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/","og_locale":"en_US","og_type":"article","og_title":"Program in Health Economics and Outcomes Research Methodology (PHEnOM) - School of Pharmacy","og_description":"The Program in Health Economics and Outcomes Research Methodology (PHEnOM) at The CHOICE Institute is a joint program with the Department of Health Systems & Population Health in the School of Public Health at the...","og_url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/","og_site_name":"School of Pharmacy","article_publisher":"http:\/\/www.facebook.com\/UWSOP","article_modified_time":"2026-05-04T23:01:54+00:00","og_image":[{"url":"https:\/\/sop.washington.edu\/wp-content\/uploads\/Doug-Barthold_sq-300x300.jpg","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@UW_Pharmacy","twitter_misc":{"Est. reading time":"30 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/","name":"Program in Health Economics and Outcomes Research Methodology (PHEnOM) - School of Pharmacy","isPartOf":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/#primaryimage"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/#primaryimage"},"thumbnailUrl":"https:\/\/sop.washington.edu\/wp-content\/uploads\/Doug-Barthold_sq-300x300.jpg","datePublished":"2017-12-04T18:55:02+00:00","dateModified":"2026-05-04T23:01:54+00:00","breadcrumb":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/#primaryimage","url":"https:\/\/sop.washington.edu\/wp-content\/uploads\/Doug-Barthold_sq-300x300.jpg","contentUrl":"https:\/\/sop.washington.edu\/wp-content\/uploads\/Doug-Barthold_sq-300x300.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/phenom\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/"},{"@type":"ListItem","position":2,"name":"The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/"},{"@type":"ListItem","position":3,"name":"Research","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/"},{"@type":"ListItem","position":4,"name":"Programs","item":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/choice\/research\/programs\/"},{"@type":"ListItem","position":5,"name":"Program in Health Economics and Outcomes Research Methodology (PHEnOM)"}]},{"@type":"WebSite","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#website","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","name":"University of Washington School of Pharmacy","description":"University of Washington","publisher":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization"},"alternateName":"UW School of Pharmacy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#organization","name":"University of Washington School of Pharmacy","alternateName":"UW School of Pharmacy","url":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/","url":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","contentUrl":"https:\/\/sop.washington.edu\/wp-content\/uploads\/W-Logo.png","width":526,"height":527,"caption":"University of Washington School of Pharmacy"},"image":{"@id":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/#\/schema\/logo\/image\/"},"sameAs":["http:\/\/www.facebook.com\/UWSOP","https:\/\/x.com\/UW_Pharmacy","https:\/\/www.instagram.com\/uw_pharmacy\/","https:\/\/www.youtube.com\/user\/UWPharmacySchool","https:\/\/www.linkedin.com\/groups\/3820716"]}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages\/18477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/comments?post=18477"}],"version-history":[{"count":0,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages\/18477\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/pages\/18475"}],"wp:attachment":[{"href":"https:\/\/staff.washington.edu\/twentzel\/wordpress\/wp-json\/wp\/v2\/media?parent=18477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}